ARCHIVES

Did Iressa Data Merit Approval? Experts Discuss Implications For Drug Development, Lung Cancer Treatment, Reimbursement (12-page issue).

This article is from The Cancer Letter archive.

Vol. 29 No. 19 | May 9, 2003

Download PDF Visit The Full Archive

Related Articles

In Brief: Blumberg to direct NASA Astrobiology Institute’ Hopkins To Get $20M Donation

May 28, 1999

FDA cancer therapeutics review split among three units in reorganization.

October 10, 2003

Funding Opportunities

September 20, 2002

FDA Updates Safety Labeling Of 5-Alpha Reductase Inhibitors

June 24, 2011

White House Plans to Name Broder NCI Director, Overruling Wyngaarden, Who Support Rabson

December 2, 1988

In Brief: Less Hazardous Cigarette Only Hope To Reduce Smoking Health Problems, Carter Advisor Says

November 25, 1977